Skip to main content

Find Clinical Trials

Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

3,010 public trials 644 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Recruiting

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

NCT06529822

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more
Locations: AdventHealth Orlando, Florida, United States

Washington University School of Medicine St Louis, Missouri, United States

Ohio State University Columbus, Ohio, United States

View Trial Details

Recruiting

A Study to Investigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants With Low- to Intermediate-Risk/Low-Grade Papillary Non-Muscle Invasive Bladder Cancer

NCT07804056

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Fakultni nemocnice Motol a Homolka Prague, Czechia

View Trial Details

Recruiting

Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA

NCT06948552

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +9 more
Locations: Henry Ford Hospital Detroit, Michigan, United States

View Trial Details

Recruiting

A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases

NCT05048212

Conditions: Adenocarcinoma, Brain Diseases, Brain Metastases, +21 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

NCT05267626

Conditions: Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +57 more
Locations: Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States

START Midwest Grand Rapids, Michigan, United States

Minnesota Oncology and Hematology PA Minneapolis, Minnesota, United States

Washington University St Louis, Missouri, United States

View all 17 locations

View Trial Details

Recruiting

A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma

NCT07688187

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Research site Omaha, Nebraska, United States

View Trial Details

Recruiting

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

NCT05327686

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Kingman Regional Medical Center Kingman, Arizona, United States

Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

View all 328 locations

View Trial Details

Recruiting

Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA

NCT07828704

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Henry Ford Health Detroit, Michigan, United States

View Trial Details

Recruiting

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

NCT07297667

Conditions: Adenocarcinoma, Alveolar Soft Part Sarcoma, Breast Diseases, +25 more
Locations: Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada

University Health Network Toronto, Ontario, Canada

The Research Institute of the McGill University Montreal, Quebec, Canada

View Trial Details

Recruiting

Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer

NCT07667335

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Locally Advanced Bladder Urothelial Carcinoma, +23 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details